Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Increase in bone turnover markers in HIV patients treated with tenofovir disoproxil fumarate combined with raltegravir or efavirenz.
Bone Rep. 2020 Oct 16;13:100727. doi: 10.1016/j.bonr.2020.100727. eCollection 2020 Dec.
Bone Rep. 2020.
PMID: 33163587
Free PMC article.
Thus, therapy that optimize bone turnover is needed to reduce bone loss at this vulnerable period and improve long-term bone health....
Thus, therapy that optimize bone turnover is needed to reduce bone loss at this vulnerable period and improve long-term bone health.. …
The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women.
Dresner-Pollak R, Mayer M, Hochner-Celiniker D.
Dresner-Pollak R, et al.
Calcif Tissue Int. 2000 Feb;66(2):104-7. doi: 10.1007/s002230010022.
Calcif Tissue Int. 2000.
PMID: 10652956
Clinical Trial.
We examined whether early changes in serum bone alkaline phosphatase (B-ALP) predict long-term BMD changes in postmenopausal women on HRT. Ninety women within 1 year of menopause were randomly assigned to continuous or sequential estrogen/progestin (beta estradiol/norethis …
We examined whether early changes in serum bone alkaline phosphatase (B-ALP) predict long-term BMD changes in postmenopausal women on …
Item in Clipboard
Cite
Cite